176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
25.52%
Revenue growth above 1.5x MRVL's 4.85%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
13.52%
Gross profit growth 1.25-1.5x MRVL's 9.90%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
-33.30%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-33.30%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-32.17%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-32.43%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-32.43%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.33%
Slight or no buybacks while MRVL is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.64%
Diluted share count expanding well above MRVL's 0.61%. Michael Burry would fear significant dilution to existing owners' stakes.
0.69%
Dividend growth under 50% of MRVL's 1.76%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
72.39%
OCF growth above 1.5x MRVL's 28.58%. David Dodd would confirm a clear edge in underlying cash generation.
79.05%
FCF growth above 1.5x MRVL's 50.23%. David Dodd would verify if the firm’s strategic investments yield superior returns.
343.12%
Positive 10Y revenue/share CAGR while MRVL is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
194.48%
Positive 5Y CAGR while MRVL is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
68.02%
Positive 3Y CAGR while MRVL is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
4142.41%
Positive long-term OCF/share growth while MRVL is negative. John Neff would see a structural advantage in sustained cash generation.
744.30%
5Y OCF/share CAGR 1.25-1.5x MRVL's 566.76%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
115.41%
3Y OCF/share CAGR above 1.5x MRVL's 69.79%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
510.29%
Positive 10Y CAGR while MRVL is negative. John Neff might see a substantial advantage in bottom-line trajectory.
2001.04%
5Y net income/share CAGR above 1.5x MRVL's 67.59%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
3.40%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
368.66%
10Y equity/share CAGR above 1.5x MRVL's 66.40%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
191.99%
5Y equity/share CAGR above 1.5x MRVL's 56.78%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
125.76%
3Y equity/share CAGR above 1.5x MRVL's 61.24%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
64.05%
5Y dividend/share CAGR above 1.5x MRVL's 0.95%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
14.22%
3Y dividend/share CAGR above 1.5x MRVL's 1.48%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
9.28%
AR growth well above MRVL's 3.15%. Michael Burry fears inflated revenue or higher default risk in the near future.
24.20%
We show growth while MRVL is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
8.28%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
5.88%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
1.54%
Debt growth far above MRVL's 0.06%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
35.65%
We increase R&D while MRVL cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
113.99%
We expand SG&A while MRVL cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.